PMC:7204657 / 1599-1827 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"71","span":{"begin":112,"end":123},"obj":"Chemical"},{"id":"75","span":{"begin":136,"end":144},"obj":"Disease"}],"attributes":[{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:C502936"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T12","span":{"begin":84,"end":94},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma7199"}],"text":"More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":84,"end":106},"obj":"Disease"},{"id":"T18","span":{"begin":136,"end":144},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0006807"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T22","span":{"begin":84,"end":94},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T23","span":{"begin":84,"end":94},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"}],"text":"More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":112,"end":123},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":"More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event."}

{"project":"LitCovid-sentences","denotations":[{"id":"T14","span":{"begin":0,"end":228},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T8","span":{"begin":84,"end":106},"obj":"Phenotype"}],"attributes":[{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0031368"}],"text":"More studies are required to evaluate whether these variables influence the risk of intestinal perforation with tocilizumab in critical COVID-19 cases; however, clinicians should be aware of the potential for this adverse event."}